Atlas FDA

Xstim Spine Fusion Stimulator

FDA premarket approval P230025/S001 · decided 2024-11-12

Approval details

PMA number
P230025
Supplement
S001
Supplement type
Real-Time Process
Supplement reason
Change Design/Components/Specifications/Material
Trade name
Xstim Spine Fusion Stimulator
Generic name
Stimulator, bone growth, non-invasive
Applicant
Xstim, Inc.
Date received
2024-08-14
Decision date
2024-11-12
Days to decision
90 days
Decision code
APPR
Product code
LOF
Advisory committee
Orthopedic
Expedited review
No
Location
Irving, TX
Statement
Approval for a software change to extend the maximum total device activation time of the Xstim Spine Fusion Stimulator from 400 days to 1100 days.

Class III intelligence, same tools

PMAs share the API, exports and alerts with 510(k) data - watch an applicant and hear about every approval.